Xeris Biopharma Down Over 21%, On Pace for Largest Percent Decrease Since June 2020 -- Data Talk

Dow Jones11-07

Xeris Biopharma Holdings, Inc. $(XERS)$ is currently at $7.78, down $2.10 or 21.23%

--Would be lowest close since Sept. 19, 2025, when it closed at $7.72

--On pace for largest percent decrease since June 25, 2020, when it fell 48.78%

--Currently down two consecutive days; down 21.46% over this period

--Worst two-day stretch since the two days ending Jan. 4, 2023, when it fell 21.8%

--Up 129.35% year-to-date; on pace for best year on record (Based on available data back to June 21, 2018)

--Down 71.45% from its all-time closing high of $27.23 on Sept. 10, 2018

--Up 131.4% from 52 weeks ago (Nov. 7, 2024), when it closed at $3.36

--Down 21.46% from its 52-week closing high of $9.90 on Nov. 4, 2025

--Up 168.1% from its 52-week closing low of $2.90 on Nov. 18, 2024

--Traded as low as $7.76; lowest intraday level since Sept. 25, 2025, when it hit $7.72

--Down 21.43% at today's intraday low; largest intraday percent decrease since March 6, 2024, when it fell as much as 21.43%

All data as of 1:24:14 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 06, 2025 13:33 ET (18:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2581567019?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 02:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581567019","market":"other","top_or_hot":-1,"title":"Xeris Biopharma Down Over 21%, On Pace for Largest Percent Decrease Since June 2020 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Xeris Biopharma Holdings, Inc. <a href=\"https://laohu8.com/S/XERS\">$(XERS)$</a> is currently at $7.78, down $2.10 or 21.23% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 19, 2025, when it closed at $7.72 \n</p>\n<p>\n     --On pace for largest percent decrease since June 25, 2020, when it fell 48.78% \n</p>\n<p>\n     --Currently down two consecutive days; down 21.46% over this period \n</p>\n<p>\n     --Worst two-day stretch since the two days ending Jan. 4, 2023, when it fell 21.8% \n</p>\n<p>\n     --Up 129.35% year-to-date; on pace for best year on record (Based on available data back to June 21, 2018) \n</p>\n<p>\n     --Down 71.45% from its all-time closing high of $27.23 on Sept. 10, 2018 \n</p>\n<p>\n     --Up 131.4% from 52 weeks ago (Nov. 7, 2024), when it closed at $3.36 \n</p>\n<p>\n     --Down 21.46% from its 52-week closing high of $9.90 on Nov. 4, 2025 \n</p>\n<p>\n     --Up 168.1% from its 52-week closing low of $2.90 on Nov. 18, 2024 \n</p>\n<p>\n     --Traded as low as $7.76; lowest intraday level since Sept. 25, 2025, when it hit $7.72 \n</p>\n<p>\n     --Down 21.43% at today's intraday low; largest intraday percent decrease since March 6, 2024, when it fell as much as 21.43% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 1:24:14 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 13:33 ET (18:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xeris Biopharma Down Over 21%, On Pace for Largest Percent Decrease Since June 2020 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXeris Biopharma Down Over 21%, On Pace for Largest Percent Decrease Since June 2020 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-07 02:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Xeris Biopharma Holdings, Inc. <a href=\"https://laohu8.com/S/XERS\">$(XERS)$</a> is currently at $7.78, down $2.10 or 21.23% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be lowest close since Sept. 19, 2025, when it closed at $7.72 \n</p>\n<p>\n     --On pace for largest percent decrease since June 25, 2020, when it fell 48.78% \n</p>\n<p>\n     --Currently down two consecutive days; down 21.46% over this period \n</p>\n<p>\n     --Worst two-day stretch since the two days ending Jan. 4, 2023, when it fell 21.8% \n</p>\n<p>\n     --Up 129.35% year-to-date; on pace for best year on record (Based on available data back to June 21, 2018) \n</p>\n<p>\n     --Down 71.45% from its all-time closing high of $27.23 on Sept. 10, 2018 \n</p>\n<p>\n     --Up 131.4% from 52 weeks ago (Nov. 7, 2024), when it closed at $3.36 \n</p>\n<p>\n     --Down 21.46% from its 52-week closing high of $9.90 on Nov. 4, 2025 \n</p>\n<p>\n     --Up 168.1% from its 52-week closing low of $2.90 on Nov. 18, 2024 \n</p>\n<p>\n     --Traded as low as $7.76; lowest intraday level since Sept. 25, 2025, when it hit $7.72 \n</p>\n<p>\n     --Down 21.43% at today's intraday low; largest intraday percent decrease since March 6, 2024, when it fell as much as 21.43% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 1:24:14 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 13:33 ET (18:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2581567019","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581567019","pubTimestamp":1762453980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Xeris Biopharma Holdings, Inc.  is currently at $7.78, down $2.10 or 21.23%. --Would be lowest close since Sept. 19, 2025, when it closed at $7.72. --On pace for largest percent decrease since June 25, 2020, when it fell 48.78%. --Currently down two consecutive days; down 21.46% over this period. --Up 129.35% year-to-date; on pace for best year on record . --Down 71.45% from its all-time closing high of $27.23 on Sept. 10, 2018. --Up 131.4% from 52 weeks ago , when it closed at $3.36. --Traded as low as $7.76; lowest intraday level since Sept. 25, 2025, when it hit $7.72. --Down 21.43% at today's intraday low; largest intraday percent decrease since March 6, 2024, when it fell as much as 21.43%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","XERS":"Xeris制药"},"translate_title":"Xeris Biopharma股价下跌超过21%，创2020年6月以来最大跌幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XERS":1},"content_text":"Xeris Biopharma Holdings, Inc. $(XERS)$ is currently at $7.78, down $2.10 or 21.23% \n\n\n \n\n\n     --Would be lowest close since Sept. 19, 2025, when it closed at $7.72 \n\n\n     --On pace for largest percent decrease since June 25, 2020, when it fell 48.78% \n\n\n     --Currently down two consecutive days; down 21.46% over this period \n\n\n     --Worst two-day stretch since the two days ending Jan. 4, 2023, when it fell 21.8% \n\n\n     --Up 129.35% year-to-date; on pace for best year on record (Based on available data back to June 21, 2018) \n\n\n     --Down 71.45% from its all-time closing high of $27.23 on Sept. 10, 2018 \n\n\n     --Up 131.4% from 52 weeks ago (Nov. 7, 2024), when it closed at $3.36 \n\n\n     --Down 21.46% from its 52-week closing high of $9.90 on Nov. 4, 2025 \n\n\n     --Up 168.1% from its 52-week closing low of $2.90 on Nov. 18, 2024 \n\n\n     --Traded as low as $7.76; lowest intraday level since Sept. 25, 2025, when it hit $7.72 \n\n\n     --Down 21.43% at today's intraday low; largest intraday percent decrease since March 6, 2024, when it fell as much as 21.43% \n\n\n \n\n\n     All data as of 1:24:14 PM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 13:33 ET (18:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581567019","isCrawlerRequest":true}